Exclusive

Publication

Byline

US Patent Issued to Ventana Medical Systems on July 7 for "Conjugates including a detectable moiety" (Costa Rican Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,938, issued on July 7, was assigned to Ventana Medical Systems Inc. (Tucson, Ariz.). "Conjugates including a detectable moiety" was invented... Read More


US Patent Issued to Karyopharm Therapeutics on July 7 for "Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms" (Canadian, American Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,939, issued on July 7, was assigned to Karyopharm Therapeutics Inc. (Newton, Mass.). "Methods of synthesis of heteroaryl derivatives of tria... Read More


US Patent Issued to On Target Laboratories on July 7 for "Methods of manufacture and synthesis of fluorescent dye compounds and uses thereof" (Indiana Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,940, issued on July 7, was assigned to On Target Laboratories Inc. (West Lafayette, Ind.). "Methods of manufacture and synthesis of fluoresc... Read More


US Patent Issued to Sumitomo Pharma, NATIONAL CANCER CENTER on July 7 for "Tertiary amide derivatives substituted with 4-membered ring structure" (Japanese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,941, issued on July 7, was assigned to Sumitomo Pharma Co. Ltd. (Osaka, Japan) and NATIONAL CANCER CENTER (Tokyo). "Tertiary amide derivativ... Read More


US Patent Issued to Bayer on July 7 for "Azabicyclyl-substituted heterocycles as fungicides" (French, German, Swiss Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,942, issued on July 7, was assigned to Bayer AG (Leverkusen, Germany). "Azabicyclyl-substituted heterocycles as fungicides" was invented by ... Read More


US Patent Issued to BASF on July 7 for "Method for preparing an enantiomerically enriched form of 2-[2-(2-chlorothiazol-5-yl)-2-hydroxy-ethylsulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one" (German, Indian, Swiss Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,943, issued on July 7, was assigned to BASF SE (Ludwigshafen, Germany). "Method for preparing an enantiomerically enriched form of 2-[2-(2-c... Read More


US Patent Issued to YUHAN, GREEN CROSS on July 7 for "Compounds having inhibitory activity against glucosylceramide synthase or pharmaceutically acceptable salt thereof, processes for preparing the same, and pharmaceutical compositions comprising the same" (South Korean Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,944, issued on July 7, was assigned to YUHAN Corp. (Seoul, South Korea) and GREEN CROSS Corp. (Yongin-si, South Korea). "Compounds having in... Read More


US Patent Issued to Daegu-Gyeongbuk Medical Innovation Foundation, Immunoforge on July 7 for "3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-apyridin-3-yl)ethinyl)-n-phenylbenzamide derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer" (South Korean Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,945, issued on July 7, was assigned to Daegu-Gyeongbuk Medical Innovation Foundation (Daegu, South Korea) and Immunoforge Co. Ltd. (Seoul, So... Read More


US Patent Issued to RaQualia Pharma on July 7 for "Pyrimidin-4(3H)-one derivatives as TRPV4 antagonists" (Japanese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,946, issued on July 7, was assigned to RaQualia Pharma Inc. (Aichi, Japan). "Pyrimidin-4(3H)-one derivatives as TRPV4 antagonists" was inven... Read More


US Patent Issued to Cytosinlab Therapeutics on July 7 for "Pyrido-pyrazinyl compounds for treating acute myeloid leukemia" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,947, issued on July 7, was assigned to Cytosinlab Therapeutics Co. Ltd. (Shanghai). "Pyrido-pyrazinyl compounds for treating acute myeloid l... Read More